Creso Pharma welcomes new COOApril 4, 2017
Creso Pharma has appointed pharmaceutical and biotech industry professional David Russell as its Chief Operating Officer.
Russell is based in Sydney and will be responsible for assisting Creso’s CEO with the Company’s overall business and corporate strategy, the company said in its press release. Also, Russell will be responsible for developing the Australian business and the overall commercial strategy for the Company in Australia.
The company said that the appointment significantly strengthens its presence in the local market as well as its commercialisation and strategy expertise as it progresses with the development and commercialisation of its cannabinoid-derived nutraceutical products for animal and human health.
Russell has more than 25 years experience within the pharmaceutical and biotech industry with a number of companies including Roche, Actelion Pharmaceuticals, Celgene and Novogen.